The University of Chicago Header Logo

Connection

Roshni Roy Chowdhury to Omalizumab

This is a "connection" page, showing publications Roshni Roy Chowdhury has written about Omalizumab.
Connection Strength

0.203
  1. Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumab. Allergy. 2021 09; 76(9):2809-2826.
    View in: PubMed
    Score: 0.203
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.